Joann Suzich

JoAnn joined Immunocore in April, 2020 after more than 30 years at MedImmune/AstraZeneca, where she most recently was Head of Microbial Sciences. Prior to that role, JoAnn led the Research function at MedImmune. Long considered one of the world’s leading infectious disease experts, JoAnn was responsible for critical studies that led to the development of the human papilloma virus vaccine for preventing cervical cancer. She was also involved in the development of the only FDA approved monoclonal antibody for preventing a viral disease. JoAnn serves on the Board of Evaxion Biotech, is a member of the Scientific Advisory Board for the Institute for Bioscience and Biotechnology Research at the University of Maryland and is on the Scientific Steering Committee for the Human Vaccines Project. She earned her PhD in Biochemistry from Purdue University and completed a Postdoctoral Fellowship in Biochemistry at the University of Minnesota. She is widely published and holds four patents.